Hemodialysis

Rockwell Medical, Inc. Appoints John P. McLaughlin Chairman of the Board of Directors

Retrieved on: 
Thursday, October 31, 2019
Medicine, Membrane technology, Clinical medicine, Renal dialysis, Detoxification, Dialysis, Hemodialysis, Nephrology, Rockwell Medical

Mr. McLaughlin, who joined the Board on September 5, 2019, succeeds Benjamin Wolin, who will remain on the Board of Directors.

Key Points: 
  • Mr. McLaughlin, who joined the Board on September 5, 2019, succeeds Benjamin Wolin, who will remain on the Board of Directors.
  • Triferic.
  • We are grateful to Ben for his service as Chairman, and we are excited that he will remain an active member of the Board, said John P. McLaughlin, Chairman of the Board.
  • Triferic is the only FDA-approved therapy indicated to replace iron and maintain hemoglobin in hemodialysis patients via dialysate during each dialysis treatment.

Pursuit Vascular Announces Participation at American Society of Nephrology Annual Meeting

Retrieved on: 
Wednesday, October 30, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Hemodialysis, Dialysis catheter, Bacteremia

MAPLE GROVE, Minn., Oct. 30, 2019 /PRNewswire/ --Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Barrier Caps, today announced the company will be exhibiting at the American Society of Nephrology (ASN) Scientific Exposition taking place in Washington DC next week.

Key Points: 
  • MAPLE GROVE, Minn., Oct. 30, 2019 /PRNewswire/ --Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Barrier Caps, today announced the company will be exhibiting at the American Society of Nephrology (ASN) Scientific Exposition taking place in Washington DC next week.
  • ASN and the U.S. Department of Health and Human Services established the Kidney Innovation Accelerator (KidneyX), to encourage new therapies in the kidney space.
  • ClearGuard HD caps have been proven to reduce bloodstream infections by ~70% in hemodialysis catheter patients.
  • Headquartered in Maple Grove, Minnesota, Pursuit Vascular, Inc., develops innovative products designed to protect patients from life-threatening infections, their associated complications, and death, while reducing healthcare costs worldwide.

Worldwide Dialyzer Market Forecasts to 2025 - A $4.53 Billion Industry Opportunity - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 23, 2019
Medical devices, Health, Membrane technology, Actuarial science, Compound annual growth rate, Mathematical finance, Non-Newtonian calculus, Hemodialysis

Based on type, the high-flux dialyzer segment accounted for nearly half share of the dialyzer industry in 2017.

Key Points: 
  • Based on type, the high-flux dialyzer segment accounted for nearly half share of the dialyzer industry in 2017.
  • The home dialyzer segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • Asia-Pacific is anticipated to grow at the highest rate in the dialyzer market during the analysis period, followed by LAMEA.
  • Based on type, the high-flux dialyzer segment was the highest contributor toward market growth in 2017 and is expected to maintain its dominance during the forecast period.

More People in Phnom Penh Living With Kidney Disease Will Have Access to Dialysis From Today

Retrieved on: 
Thursday, October 17, 2019
Hospitals, Health, Medical devices, Medicine, Clinical medicine, Membrane technology, Health, Detoxification, Dialysis, Fresenius Medical Care, Renal dialysis, Northwest Kidney Centers, Hemodialysis

The new dialysis clinic at HMC, which will be Cambodias first dialysis center of excellence, will be officially opened today.

Key Points: 
  • The new dialysis clinic at HMC, which will be Cambodias first dialysis center of excellence, will be officially opened today.
  • Our goal is to enhance access to affordable, quality dialysis care for more people throughout the country.
  • Today, we are proud that for the first time, we can extend that care to people in need of life-sustaining dialysis.
  • Through its network of 3,996 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 339,550 patients around the globe.

Former Time Warner and HBO CEO Gerald Levin Joins Dialyze Direct as Chief Mission Officer

Retrieved on: 
Wednesday, October 2, 2019
Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Home hemodialysis, Dialysis, Hemodialysis, Northwest Kidney Centers

Levin has recently been diagnosed with kidney failure and brings personal experience as a dialysis patient to Dialyze Direct.

Key Points: 
  • Levin has recently been diagnosed with kidney failure and brings personal experience as a dialysis patient to Dialyze Direct.
  • Levin is charged with driving patient-centered innovation for geriatric patients, who currently make up approximately half of all dialysis patients.
  • Dialyze Direct is the country's largest provider of on-site home hemodialysis in nursing homes.
  • Dialyze Direct has created a dialysis model resulting in significantly improved patient outcomes and quality of life while substantially decreasing costs for payors.

Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

Retrieved on: 
Tuesday, September 24, 2019
Medicine, Clinical medicine, Health, Membrane technology, Rockwell Medical, Renal dialysis, Hemodialysis, Prescription Drug User Fee Act, Dialysis, Food and Drug Administration

Rockwell Medical's exclusive renal drug therapy, Triferic, is the only FDA-approved therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.

Key Points: 
  • Rockwell Medical's exclusive renal drug therapy, Triferic, is the only FDA-approved therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.
  • Triferic, for which the Company filed a New Drug Application in May 2019.
  • Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.
  • Triferic, for which the Company filed a New Drug Application in May 2019 with a PDUFA date of March 28, 2020.

Fresenius Medical Care Launches 4008A™ Dialysis Machine in China

Retrieved on: 
Thursday, September 19, 2019
Medical devices, Health, Hospitals, Other Health, Membrane technology, Natural sciences, Medicine, Clinical medicine, Fresenius Medical Care, Fresenius, Dialysis, Hemodialysis

Fresenius Medical Care, the worlds leading provider of dialysis products and services, today announced the launch of its 4008ATM dialysis machine in China.

Key Points: 
  • Fresenius Medical Care, the worlds leading provider of dialysis products and services, today announced the launch of its 4008ATM dialysis machine in China.
  • View the full release here: https://www.businesswire.com/news/home/20190919005325/en/
    Fresenius Medical Care proudly launched the 4008A dialysis machine in China today.
  • It is important to enhance the accessibility and affordability of dialysis in primary care, especially in the rural regions in China, Mr. Alan Chen, Executive Vice President of Fresenius Medical Care, Greater China said.
  • Through its network of 3,996 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 339,550 patients around the globe.

Global Dialysis Market to 2025 by Type (Hemodialysis, Peritoneal Dialysis), End-Use, Product & Service, Regions, and Company - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 10, 2019
Medical devices, Health, Medicine, Clinical medicine, Renal dialysis, Membrane technology, RTT, Nephrology, Detoxification, Dialysis, Hemodialysis, Peritoneal dialysis, Chronic kidney disease, Draft:Dialysis in the Philippines

The "Global Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), End-Use, Product & Service, Regions (North America, Europe, Asia Pacific, Rest of the World), and Company" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Dialysis Market by Type (Hemodialysis, Peritoneal Dialysis), End-Use, Product & Service, Regions (North America, Europe, Asia Pacific, Rest of the World), and Company" report has been added to ResearchAndMarkets.com's offering.
  • Global Dialysis Market is expected to be more than US$ 118 Billion by 2025.
  • Globally dialysis market is increasing due to growth in the number of end-stage renal disease patient numbers.
  • The service segment is a clear winner in the global dialysis market.

IN.PACT AV Access Trial Meets Primary Safety and Effectiveness Endpoints

Retrieved on: 
Saturday, September 7, 2019
Medicine, Clinical medicine, Renal dialysis, Hemodialysis, Membrane technology, Interventional radiology, Cardiovascular and Interventional Radiological Society of Europe, Arteriovenous fistula

The study met primary safety and effectiveness endpoints and data were presented today at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) annual meeting in Barcelona, Spain.

Key Points: 
  • The study met primary safety and effectiveness endpoints and data were presented today at the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) annual meeting in Barcelona, Spain.
  • AV fistulae, otherwise known as AV access sites, are created and used to deliver hemodialysis to patients with end-stage renal disease (ESRD).
  • The IN.PACT AV Access study is a randomized controlled trial (RCT), which has enrolled 330 subjects at 29 sites in United States, Japan, and New Zealand.
  • The primary effectiveness endpoint was defined as freedom from clinically-driven target lesion revascularization (CD-TLR) or access circuit thrombosis measured through six months post-procedure and the primary safety endpoint was defined as the serious adverse event rate involving the AV Access circuit through 30 days post-procedure.

Concerto Renal Services adds Autumn Lake Healthcare in Baltimore, Maryland to its SNF Dialysis Program

Retrieved on: 
Thursday, August 29, 2019
Medicine, Clinical medicine, Health, Renal dialysis, Membrane technology, Detoxification, Dialysis, Home hemodialysis, Hemodialysis, Nursing home care

BALTIMORE, Aug. 29, 2019 /PRNewswire-PRWeb/ --Concerto Renal Services (Concerto), one of the nation's leading providers of staff-assisted home hemodialysis services in Skilled Nursing Facility (SNF), welcomes Autumn Lake Healthcare's Post Acute facility in Baltimore to its SNF Dialysis Program.

Key Points: 
  • BALTIMORE, Aug. 29, 2019 /PRNewswire-PRWeb/ --Concerto Renal Services (Concerto), one of the nation's leading providers of staff-assisted home hemodialysis services in Skilled Nursing Facility (SNF), welcomes Autumn Lake Healthcare's Post Acute facility in Baltimore to its SNF Dialysis Program.
  • Concerto Chief Executive Officer, Shimmy Meystel is "thrilled to bring our model of coordinated onsite dialysis care to Autumn Lake Healthcare and welcome a partnership with this well-respected national operator.
  • It has given Concerto and Maryland nursing home dialysis patients reason to be excited and relieved."
  • Autumn Lake Healthcare maintains a network of independent nursing homes and rehabilitative care centers across Connecticut, New Jersey, and Maryland and Wisconsin.